A startup seeking to replace animal testing with a sophisticated high-tech platform has raised $40 million to develop ...

A start-up that launched only 8 months ago has attracted the attention of Biogen, a major developer of neurological drugs.

The stock value and growth potential of a biotech firm depend on the type of diseases it treats. This might also include the research that the firm does as it supports other companies, diseases or ...

but another health emergency or issue could allow a different firm to rise out of nowhere. You must always be on the lookout. Best Online Brokers for Biotech Penny Stock You will need a trading ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Actus Biotechnologies wants to go a step beyond job creation - to business creation. Managing Director John Muraski, a Marana resident who helped expand the company from its Las Vegas headquarters ...

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients ...

Novo Holdings led a $92 million Series A investment in Kivu Biosciences, a San Francisco biotech focusing on the development of antibody-drug conjugates for solid tumours. Like other ADC start-ups ...

Real time quote data is not available at this time. Nasdaq Data Link is a marketplace for financial, economic and alternative data delivered in modern formats for today's analysts, including ...